‘Financial toxicity’ alive and well in medicine

Failure by doctors to inform patients of the full financial cost of a treatment, along with viable alternatives, risks poorer compliance and additional suffering, argue two Australian cancer experts.

Writing in the MJA, Professor Sanchia Aranda from the Cancer Council and Professor David Currow from the Cancer Institute NSW bemoan the prevalence of “financial toxicity” in clinical care.